Cyclopharm Limited reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was AUD 11.41 million compared to AUD 8.34 million a year ago. Revenue was AUD 11.43 million compared to AUD 8.48 million a year ago.

Net loss was AUD 2.56 million compared to AUD 3.93 million a year ago. Basic loss per share from continuing operations was AUD 0.0278 compared to AUD 0.0446 a year ago. Diluted loss per share from continuing operations was AUD 0.0278 compared to AUD 0.0446 a year ago.